WASHINGTON, Aug 7 (Reuters) - The U.S. Justice

Department said on Thursday it required broad divestitures to

resolve a challenge to Unitedhealth's ( UNH ) $3.3 billion acquisition

of Amedisys ( AMED ).

"In addition, Amedisys ( AMED ) would pay a $1.1 million civil

penalty to the United States for falsely certifying that it had

provided 'true, correct, and complete' responses" under

antitrust law, it said in a statement.